Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assessment of 'DRISTi' as an Automated Diabetic Retinopathy Screening Tool in Diabetic Populations

NCT07222293 is registered in ClinicalTrials.gov with Artelus AI as lead sponsor.

NCT NCT07222293
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07222293 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assessment of 'DRISTi' as an Automated Diabetic Retinopathy Screening Tool in Diabetic Populations
Lead sponsor
Artelus AI
Phase
Observational
Overall status
Recruiting
Start date
November 23, 2025
Completion date
March 31, 2026
Enrollment
900 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

diabetic retinopathy (dr)